Becton, Dickinson & Co. (BDX)
177.81
-2.81
(-1.56%)
USD |
NYSE |
Feb 12, 16:00
177.81
0.00 (0.00%)
After-Hours: 20:00
Becton, Dickinson Free Cash Flow : 2.631B for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| West Pharmaceutical Services, Inc. | 379.10M |
| Abbott Laboratories | 6.917B |
| Baxter International, Inc. | 235.00M |
| Boston Scientific Corp. | 3.824B |
| Integra LifeSciences Holdings Corp. | -14.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 657.00M |
| Cash from Investing (Quarterly) | -183.00M |
| Cash from Financing (Quarterly) | -302.00M |
| Free Cash Flow Per Share (Quarterly) | 1.921 |
| Free Cash Flow to Equity (Quarterly) | 1.03B |
| Free Cash Flow to Firm (Quarterly) | 697.72M |
| Free Cash Flow Yield | 5.16% |